EMEA-002359-PIP01-18-M05
Key facts
Invented name |
Efluelda
|
Active substance |
|
Therapeutic area |
Vaccines
|
Decision number |
P/0219/2022
|
PIP number |
EMEA-002359-PIP01-18-M05
|
Pharmaceutical form(s) |
Suspension for injection
|
Condition(s) / indication(s) |
Prevention of influenza infection
|
Route(s) of administration |
Intramuscular use
|
Contact for public enquiries |
Sanofi Pasteur
E-mail: contact-us@sanofi.com |
Decision type |
PM: decision on the application for modification of an agreed PIP
|